Total Payments
$135,195
2024 Payments
$1,290
Companies
32
Transactions
444
Payment Breakdown by Category
Research$42,985 (31.8%)
Consulting$41,116 (30.4%)
Other$22,450 (16.6%)
Travel$15,978 (11.8%)
Food & Beverage$12,496 (9.2%)
Education$171.06 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $42,985 | 20 | 31.8% |
| Consulting Fee | $41,116 | 14 | 30.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,450 | 11 | 16.6% |
| Travel and Lodging | $15,978 | 37 | 11.8% |
| Food and Beverage | $12,496 | 353 | 9.2% |
| Education | $171.06 | 9 | 0.1% |
Payments by Type
General
$92,210
424 transactions
Research
$42,985
20 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $76,863 | 148 | $0 (2022) |
| Eli Lilly and Company | $37,702 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $5,110 | 17 | $0 (2024) |
| Biofrontera Inc. | $3,485 | 6 | $0 (2019) |
| Galderma Laboratories, L.P. | $2,280 | 76 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $2,101 | 24 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $1,798 | 10 | $0 (2018) |
| ABBVIE INC. | $1,269 | 53 | $0 (2024) |
| Almirall LLC | $925.04 | 2 | $0 (2021) |
| Janssen Research & Development, LLC | $917.75 | 11 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,290 | 37 | REVANCE THERAPEUTICS, INC. ($449.17) |
| 2023 | $1,140 | 38 | AbbVie Inc. ($622.10) |
| 2022 | $1,202 | 31 | Merz North America, Inc. ($431.26) |
| 2021 | $2,172 | 38 | Almirall LLC ($925.04) |
| 2020 | $7,819 | 30 | Allergan, Inc. ($7,102) |
| 2019 | $75,008 | 78 | Allergan Inc. ($37,189) |
| 2018 | $13,981 | 77 | Allergan Inc. ($6,562) |
| 2017 | $32,583 | 115 | Allergan Inc. ($25,403) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Dermatology | ||||||
| 12/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $101.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/11/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $48.07 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.21 | General |
| 11/07/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $43.52 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $33.52 | General |
| 09/11/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $5.81 | General |
| 08/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $45.47 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/23/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $38.70 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/29/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $71.73 | General |
| 05/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $137.12 | General |
| 04/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 24-WEEK MULTICENTER, RANDOMIZED, BLINDED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF IXEKIZUMAB TO GUSELKUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS | Eli Lilly and Company | $37,702 | 4 |
| A randomized, double blind, vehicle-co ntrolled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). | Biofrontera Inc. | $3,485 | 6 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of EN3835 In The Treatment Of Edematous Fibrosclerotic Panniculopathy Cellulite | Endo Pharmaceuticals Inc. | $1,798 | 10 |
About Dr. Suzanne Bruce, M.D
Dr. Suzanne Bruce, M.D is a Dermatology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588661979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Bruce, M.D has received a total of $135,195 in payments from pharmaceutical and medical device companies, with $1,290 received in 2024. These payments were reported across 444 transactions from 32 companies. The most common payment nature is "" ($42,985).
Ad
Practice Information
- Specialty Dermatology
- Location Houston, TX
- Active Since 06/30/2005
- Last Updated 04/25/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588661979
Products in Payments
- TALTZ (Drug) $37,890
- BOTOX (Biological) $6,121
- COSENTYX (Biological) $4,906
- Ameluz (Drug) $3,407
- BOTOX COSMETIC (Biological) $2,594
- RHOFADE (Drug) $1,651
- Klisyri (Drug) $925.04
- DAXXIFY (Drug) $449.17
- EUCRISA (Drug) $340.82
- KYBELLA (Biological) $283.15
- ALTRENO (Drug) $230.94
- COSENTYX (Drug) $204.44
- Finacea (Drug) $170.59
- Otezla (Drug) $149.94
- SKYRIZI (Biological) $135.78
- Xeomin (Biological) $123.26
- ONEXTON (Drug) $121.18
- Humira (Biological) $120.55
- SOLODYN (Drug) $119.27
- AKLIEF (Drug) $114.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Houston
Dr. Alpesh Desai
Dermatology — Payments: $1.4M
Dermatology $1.4M
Dr. Michael Migden, Md, MD
Dermatology — Payments: $379,143
Dermatology $379,143
Dr. Geeta Patel, D.o, D.O
Dermatology — Payments: $341,210
Dermatology $341,210
Catherine Papasakelariou, M.d, M.D
Dermatology — Payments: $270,262
Dermatology $270,262
Megan Couvillion, Md, MD
Dermatology — Payments: $154,211
Dermatology $154,211
Dr. Jennifer Deaver, Md, MD
Dermatology — Payments: $132,895
Dermatology $132,895